Hedge Fund - Braidwell LP
Bridgebio Pharma Inc. (BBIO) NOTE 2.500% 3/1
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q3 (2024-09-30) | $145,613,126 | 4.12% | 140,838,000 | $26.25 |
2 | 2024 - Q2 (2024-06-30) | $142,965,899 | 4.48% | 140,838,000 | $27.34 |
3 | 2024 - Q1 (2024-03-31) | $146,211,682 | 4.71% | 135,838,000 | $34.01 |
4 | 2023 - Q4 (2023-12-31) | $138,406,149 | 5.08% | 114,338,000 | $30.03 |
5 | 2023 - Q3 (2023-09-30) | $109,764,480 | 3.46% | 114,338,000 | $28.38 |
6 | 2023 - Q2 (2023-06-30) | $101,094,132 | 3.3% | 128,338,000 | $15.05 |
7 | 2023 - Q1 (2023-03-31) | $106,213,458 | 3.5% | 143,338,000 | $11.66 |
8 | 2022 - Q4 (2022-12-31) | $63,675,000 | 2.13% | 141,500,000 | $9.57 |
The displayed share prices are average quarterly stock market prices.